Top compounds associated with response to MYL10


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.095 0.001
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA PLX4720 CCLE pan-cancer AAC 0.13 0.002
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA FH535 GDSC1000 pan-cancer AAC 0.097 0.004
mRNA Topotecan CCLE pan-cancer AAC -0.12 0.004
Download CSV